# 바이오스페이스 일일 뉴스 리포트 - 2025년 07월 04일


## 주요 헤드라인

1. **Sage’s Search for Lifeline Ran Into Defiant Biogen CEO (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sages-search-for-lifeline-ran-into-defiant-biogen-ceo>

2. **Sage’s Search for Lifeline Ran Into Defiant Biogen CEO (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/sages-search-for-lifeline-ran-into-defiant-biogen-ceo>

3. **Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/late-stage-stumble-for-cosentyx-sets-novartis-back-in-autoimmune-condition>

4. **Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/late-stage-stumble-for-cosentyx-sets-novartis-back-in-autoimmune-condition>

5. **Kennedy Follows RSV Recommendations of ACIP Members He Fired (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/kennedy-follows-rsv-recommendations-of-acip-members-he-fired>

6. **Biotech Leaders, Investors Ask FDA to Maintain Access to Mifepristone (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/biotech-leaders-investors-ask-fda-to-maintain-access-to-mifepristone>

7. **Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/gilead-eyes-hiv-market-domination-with-twice-yearly-yeztugo-as-gsk-trails>


---
*2025년 07월 04일 바이오스페이스 뉴스 피드에서 생성된 리포트*